<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A group of seven young women with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, histories of recurrent fetal loss, and no live births is reported </plain></SENT>
<SENT sid="1" pm="."><plain>Two patients had <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, and the other five fulfilled criteria for the <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A false <z:e sem="disease" ids="C0036916" disease_type="Disease or Syndrome" abbrv="std|stds">Venereal Disease</z:e> Research Laboratory (VDRL) test was present in four of the patients, three had a previous episode of arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, or both, and two had <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="8382">Prednisone</z:chebi> and <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> were given, and monthly controls of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity were carried out </plain></SENT>
<SENT sid="4" pm="."><plain>The dose of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> was fixed while the dose of steroids was adjusted according to the degree of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity </plain></SENT>
<SENT sid="5" pm="."><plain>A fetal survival was obtained in 7/9 (78%) of the pregnancies </plain></SENT>
<SENT sid="6" pm="."><plain>Three of the newborn infants had transitory <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity </plain></SENT>
<SENT sid="7" pm="."><plain>A search for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> should be carried out in patients with otherwise unexplained fetal losses, falsely positive VDRL tests, <z:mp ids='MP_0005048'>thrombosis</z:mp>, or <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> as the treatment of such patients with <z:chebi fb="0" ids="8382">prednisone</z:chebi> and <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> is highly effective </plain></SENT>
</text></document>